FY2024 Earnings Forecast for kneat.com Issued By Cormark

kneat.com, inc. (TSE:KSI) – Research analysts at Cormark increased their FY2024 EPS estimates for shares of kneat.com in a research report issued to clients and investors on Thursday, November 7th. Cormark analyst G. Fairweather now forecasts that the company will post earnings per share of ($0.08) for the year, up from their prior forecast of ($0.12). The consensus estimate for kneat.com’s current full-year earnings is ($0.12) per share. Cormark also issued estimates for kneat.com’s FY2025 earnings at ($0.02) EPS and FY2026 earnings at $0.03 EPS.

Several other research firms also recently weighed in on KSI. CIBC set a C$6.00 price target on kneat.com and gave the company an “outperform” rating in a research note on Tuesday, October 29th. Cibc World Mkts raised kneat.com to a “strong-buy” rating in a report on Tuesday, October 29th. Finally, Ventum Cap Mkts raised shares of kneat.com to a “strong-buy” rating in a research note on Wednesday, August 7th.

kneat.com Trading Down 0.2 %

TSE:KSI opened at C$4.99 on Monday. The company has a market capitalization of C$429.14 million, a P/E ratio of -31.19, a PEG ratio of 597.67 and a beta of 1.08. The company has a current ratio of 1.47, a quick ratio of 1.50 and a debt-to-equity ratio of 95.14. The firm has a fifty day simple moving average of C$4.77 and a 200-day simple moving average of C$4.52. kneat.com has a 12 month low of C$2.73 and a 12 month high of C$5.17.

About kneat.com

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.